Next Vision 2025: Orders Are Already Here; Now It Has to Prove Delivery and Capital Allocation

Company Overview

Next Vision is no longer a story about proving demand. It has already cleared that hurdle. In 2025, revenue rose to $168.4 million, net income reached $103.7 million, and year-end backlog stood at $217.8 million. By March 10, 2026, backlog had already increased to $288.0 million. That tells you quickly what is working here: customers are ordering, customers are returning, and the company has turned a relatively small product into a very profitable engine with gross margin close to 70%.

But that is exactly where the interesting part begins. The active bottleneck is no longer demand; it is converting demand into delivery, while allocating capital after a huge raise. At the end of 2025, the company held $85.4 million in cash and another $476.9 million in short-term deposits, together $562.3 million of liquidity. At the same time, inventory rose to $53.6 million, actual production ran at about 2,000 cameras per month, and management is targeting more than 4,000 units per month by the end of 2026. In other words, Next Vision is entering 2026 not as a niche supplier still looking for customers, but as a company that has to prove it can run a scaled production floor, supply chain, commercial terms, and excess capital all at once.

What can mislead a superficial reading is the bottom line. Net income looks excellent, but not all of the improvement came from operations. Gross margin fell from 72.1% in 2024 to 69.8% in 2025, and operating margin fell from 63.5% to 60.3%. What lifted net income was also a sharp increase in finance income after the September 2025 raise was moved into short-term deposits. That means the right screen for the company today is this: the business is strong, but the next phase will be decided less by whether orders keep coming and more by what those orders look like once they move through production, inventory, and the balance sheet.

As of April 3, 2026, market cap stood at about NIS 28.0 billion, daily turnover was about NIS 42.8 million, and short float was only 0.13%, versus a sector average of 0.84%. This is not a stock the market is leaning against. Quite the opposite. That raises the bar: another attractive order announcement may not change the story much, but a miss on delivery, margin, or capital deployment could easily change how the market reads 2026.

The company's economic map looks like this:

Events and Triggers

The order wave changes the question

The first trigger: the order flow from late December 2025 through late February 2026 did not just create headlines; it also exposed backlog quality. On December 15, 2025, the company received a $76.8 million order for delivery by the end of 2026, with a mechanism that can increase the order by up to another $2.9 million. After that came a $9.5 million order on December 30, 2025, a $22.1 million order on December 31, 2025, a $4.9 million order on January 15, 2026, a $60 million order on January 18, 2026, a $20 million order on January 21, 2026, and a $2.5 million order on February 25, 2026.

In total, that is $195.8 million of orders between December 15, 2025 and February 25, 2026. But backlog did not rise by the same amount. It rose from $217.8 million at the end of 2025 to $288.0 million on March 10, 2026, an increase of only $70.2 million. That is a useful signal: part of the new backlog was already being converted into shipments rather than simply piling up.

Not every backlog dollar carries the same quality

The second trigger: commercial terms are not uniform. Some of the new orders still look very favorable to the company: the $20 million order from January 21, 2026 included a 15% advance and the balance before delivery, the $22.1 million order from December 31, 2025 included two 7.5% advances plus another 15% advance in April 2026, and the $2.5 million order from February 25, 2026 included a 20% advance and the balance before delivery. But the $60 million order from January 18, 2026 looks different: net + 85 payment terms, a late-payment interest mechanism, customer compensation if deliveries are delayed by more than 7 days, and a delivery schedule that runs all the way through the end of 2029.

That is the core issue. A larger backlog is not automatically an equally strong backlog. When some contracts still come with advance payments or payment before delivery, while others come with longer credit, delay penalties, and multi-year delivery profiles, the company is buying visibility, but it is also changing the balance between margin, cash conversion, and execution risk.

The raise is already behind the company, so it becomes a different trigger

The third trigger: in September 2025, the company completed a very large equity raise, and the cash flow statement shows net proceeds of $398.4 million. That changed the structure of the story completely. Until then, Next Vision was mainly a fast-growing operating business with strong cash generation. After the raise, it also became a company carrying a very unusual level of excess capital relative to annual revenue.

That has two implications. On the one hand, it almost eliminates classic financing risk. On the other hand, it raises expectations around capital deployment. Management now explicitly says it is evaluating acquisitions in the United States and Europe, and on March 10, 2026 it also approved a $51.8 million dividend. So the trigger is no longer "does the company need cash," but rather "what capital allocation framework is it building for itself."

Efficiency, Profitability and Competition

The central number in 2025 is not just growth. It is the gap between softer gross profitability and much stronger net income. Revenue rose 46.5% to $168.4 million, gross profit rose 41.8% to $117.6 million, and operating income rose 39.1% to $101.5 million. The business clearly got larger, but gross quality did not improve in parallel. The company itself attributes the modest gross margin erosion to higher prices for some components and quantity discounts granted to major customers.

That matters because it changes how the year should be read. If growth comes together with quantity discounts and higher component costs, 2025 should not be framed only as an operating leverage story. Operationally, the company proved that it can scale. Economically, it still has to prove that it can scale without giving away terms or absorbing costs that leave less value in every unit shipped.

In the fourth quarter of 2025, revenue reached a record $47.8 million, but gross margin fell to 66.9%, down from 73.2% in the first quarter and 71.6% in the second quarter. This is not a crisis. It is still inside the company's own target range of 65% to 72%. But it is an important reminder that the next two years will not be judged only by unit volume. They will also be judged by the economic price of fulfilling those orders.

Customer structure also requires a careful read. On the positive side, active customers increased to 204 from 195 in 2024, and the company sold into 38 countries versus 34 a year earlier. On the other hand, the three material customers together accounted for 46.5% of revenue in 2025. That means the company is broader, but still far from fully diversified in economic terms. Customer A was 19.5% of revenue, Customer B 11.5%, and Customer C 15.5%.

This fits the OEM model well. About 95% of sales go to system providers rather than end users. That gives Next Vision a fast route into many platforms, but it also leaves the company dependent on the strength and quality of its customers as system manufacturers. From a profitability perspective, it is important to remember that the company sells a critical layer in the system, but it does not necessarily control the full economics of the final platform.

That said, there is still a real moat here. The company emphasizes performance-to-weight advantage, ease of integration, short development cycles, a broad product line from 115 grams to 2 kilograms, and a cadence of 2 to 3 new products each year. Direct R&D spending before capitalization reached $8.0 million in 2025 versus $4.5 million in 2024. Expensed R&D was $5.5 million, and another $2.5 million of development costs was capitalized. That is not a huge number relative to revenue, but it does signal that the company is still building out the platform rather than simply harvesting wartime demand.

Cash Flow, Debt and Capital Structure

Earnings are not the same as free cash left over

This is one of the most important gaps in the filing. Net income in 2025 was $103.7 million, but cash flow from operations was $63.6 million. The gap came mainly from a $31.2 million increase in inventory, a $5.7 million increase in receivables, and a $3.4 million increase in other current assets. Management explicitly explains that the move reflects inventory build, supplier advances, and the need for flexibility given geopolitical tensions and supply-chain risk.

That is exactly why, in Next Vision's case, it is not enough to stop at CFO, and it is not enough to stop at net income. The relevant framework here is all-in cash flexibility: how much cash was left after actual cash uses. If we start with the $63.6 million of operating cash flow and subtract reported capex of $0.34 million, capitalized development of $2.50 million, dividends of $33.20 million, and lease principal repayment of $0.41 million, the residual is roughly $27.2 million. That is still positive, but it is nowhere near the $103.7 million headline net income.

So anyone reading the company only through net income is missing two things. First, part of the bottom-line improvement came from finance income on the cash pile. Second, the business has become more working-capital intensive because it is carrying much more inventory. That is not necessarily bad. It may even be smart. But it is definitely a different economic profile from a light asset growth story that scales without balance-sheet weight.

Capital is no longer the bottleneck

On the positive side, it is difficult to ask for a stronger balance sheet. At year-end 2025, the company had $85.4 million in cash and another $476.9 million in short-term deposits. Equity reached $615.7 million. The company states explicitly that it does not use external borrowing for ongoing operations, that it has no credit lines, and that it has no effective restrictions on raising financing. At the same time, non-current lease liabilities were only $3.39 million and current lease liabilities were $0.62 million.

This is no longer a defense supplier that has to choose between growth and flexibility. It has both. That is precisely why the test shifts to capital allocation. Will this cash go into complementary acquisitions in the United States and Europe, as the company writes in its strategic objectives? Will more of it go out through dividends? Will it remain in deposits and continue generating finance income? Or will management use it to build more capacity, more inventory, and more AI-related capabilities? Each of those choices creates a very different 2026 equity story.

Outlook

Four findings that matter before looking at the 2026 target

The first finding: the 2026 revenue target of $275 million is a delivery target, not a headline target. As of March 10, 2026, backlog scheduled for 2026 delivery stood at $222.3 million. In other words, at that point backlog covered about 80.8% of the target. That is very strong for the start of a year, but it also means the company still has to produce and deliver another roughly $52.7 million beyond the backlog already visible at that date.

The second finding: a growing part of backlog is stretching further out in time. At the end of 2025, there was no backlog at all for 2028 and 2029. By March 10, 2026, that bucket already held $30.2 million. That is good for visibility, but less useful for investors focused on near-term shipment conversion. Backlog is getting larger, but part of it is also getting longer-dated.

The third finding: bottom-line improvement was helped materially by finance income. Net finance income in 2025 reached $13.1 million, versus $3.9 million in 2024. So net income improved not only because the operating business got stronger, but also because the cash pile started working.

The fourth finding: the target of more than 4,000 units per month by the end of 2026 is very ambitious relative to current output of roughly 2,000 units per month. If the company can get there without losing margin, without getting stuck with excess inventory, and without softening commercial terms too aggressively, then 2026 will look like a real proof year.

2026 is a proof year, not just a continuation year

At the beginning of January 2026, the board set a revenue target of about $275 million, implying growth of roughly 64% over 2025 revenue. At the same time, the company says it aims to keep gross margin within a 65% to 72% range. That combination defines the year's real test: it is not enough to grow; the company has to grow without dropping below the economic floor it set for itself.

If you break down the March 10, 2026 backlog, $25.8 million was scheduled for Q1 2026, $78.1 million for Q2, $81.1 million for Q3, and $37.4 million for Q4. That looks strong, but it is not evenly distributed. The first half leans heavily on Q2, and the second half leans heavily on Q3. That means even a modest operating or logistics slip can shift revenue between quarters.

What is likely to determine the market's reading over the next 2 to 4 quarters is not another order announcement. It is three other tests:

1. Whether actual revenue starts closing the gap between the $275 million target and the backlog already scheduled for delivery.
2. Whether gross margin stabilizes inside the company's target band, or whether quantity discounts, higher component costs, and rapid scale continue to push it down.
3. Whether inventory starts turning faster, rather than continuing to grow faster than revenue.

At this point, 2026 looks like a proof year with an unusual capital cushion. It is not a survival year, and it is not a reset year. The opportunity is large, but so is the potential gap between headline strength and actual delivery quality.

Risks

The first risk is growth quality. The company has already said gross margin weakened because of component cost inflation and quantity discounts. If growth increasingly comes through larger customers and more flexible commercial terms, the question will not just be how much is sold, but at what economic price.

The second risk is concentration. The top three customers accounted for almost half of 2025 revenue. In an OEM model, that is real concentration even if there are 204 active customers. Losing or delaying one major account can move an entire quarter.

The third risk is export regulation. The company operates in a market where parts of the product line require defense export or dual-use approvals. This is not theoretical. The annual filing includes a $30 million material agreement whose execution depends on regulatory approval, and by the end of 2025 approval had been received only for $2.7 million of the total amount.

The fourth risk is working capital. Inventory was an audit key matter. Management explains why it wants to carry more stock, but when inventory rises by $31.2 million in a single year, the company becomes more sensitive to demand estimation, component availability, and delivery execution.

The fifth risk is people and technology. The company explicitly notes dependence on CEO Michael Grossman and CTO Boris Kipnis, while also saying that continued expansion depends on hiring and on building AI capabilities. That combination shows how much 2026 depends not only on cameras, but on organizational execution.

The sixth risk is currency. The company's functional currency is the U.S. dollar, while a meaningful portion of expenses is in shekels and euros. As long as the dollar remains supportive, that helps. If that picture changes, margins can change with it.

Conclusions

Next Vision is entering 2026 from a position of real strength: global demand, a deep backlog, a huge cash cushion, and a product model that has clearly proven it can generate extraordinary profitability. The main bottleneck is no longer on the commercial side. It is in backlog conversion, margin protection, and the choice of a capital allocation path. In the short to medium term, the market is likely to be highly sensitive to execution quality, not just to headline momentum.

The current thesis in one line: Next Vision has already proven that its market exists. Now it has to prove that it can turn excess orders and excess cash into a durable execution machine rather than just a compelling growth story.

What has changed in the way the company should be read? In the past, it was easy to frame Next Vision as a high-margin growth company with a strong defense tailwind. Today it needs to be read through three newer variables: backlog depth, working-capital weight, and how management and the board use the cash pile they have built.

The strongest counter-thesis is that the debate around margins, commercial terms, and capital allocation may be a little early. Global demand for small unmanned systems may still be in its early innings, backlog may keep filling, and even if gross margin softens modestly, the company can absorb that comfortably because of its exceptional balance sheet and high finance income. That is a serious counter-view, but it assumes that scaling production will not materially change unit economics.

What could change the market's interpretation over the short to medium term? Mainly three things: the pace of revenue recognition in the first half of 2026, the level of gross margin after a softer fourth quarter, and whether the company makes a first meaningful capital deployment move that clarifies what it intends to do with $562.3 million of liquidity.

Why does this matter? Because Next Vision is in a relatively rare transition: from a company with a strong product in a hot market to a company that has to prove it can run an industrial growth platform without diluting the earnings quality that got it here.

For the thesis to strengthen over the next 2 to 4 quarters, the company needs to show actual deliveries at a pace that converges toward the 2026 target, stable gross margin inside the target range, slower inventory build, and first signs of a coherent capital allocation framework. What would weaken the read is delayed deliveries, persistent margin compression, or capital allocation decisions that look reactive rather than strategic.